Health Care

2540 posts
Man riding bull on a chart

Three micro-cap stocks on an upswing worth riding

It takes an encyclopedic drive to build a sense of the Canadian micro-cap stock universe and identify the highest probabilities for success.
CytoImmune Therapeutics production facility

Hemostemix stock takes off after amended manufacturing deal

Hemostemix (TSXV:HEM), a stem cell therapy stock, is up substantially after amending its manufacturing agreement with CytoImmune Therapeutics.
Breath Collection Unit

Cannabix advances marijuana breathalyzer tech

Cannabix Technologies (CSE:BLO), announced significant updates to its Cannabix marijuana breathalyzer (CMB) technology.
Innocan Pharma’s chief executive officer, Iris Bincovich

A Look into the Future of Chronic Pain Management

An interview with Innocan Pharma’s CEO, Iris Bincovich, about the company's innovative pain relief solutions.
  • Research
  • 6 mins
  • 09 January 2025 07:00 (EST)
Brazil flag on cannabis background

MediPharm Labs grows into Brazilian cannabis market

MediPharm Labs (TSX:LABS) signs an agreement with Laboratório Teuto to offer two products in the Brazilian cannabis market.
SurgiClear antimicrobial clear silicone adhesive dressing with chlorhexidine and silver

Covalon Technologies posts third profitable quarter in a row

Covalon Technologies (TSXV:COV), a healthcare technology stock, achieves net income profitability for the third straight quarter in Q4 2024.
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.
Quantum computer

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal

Cybersecurity stock Quantum eMotion (TSXV:QNC) takes a major step in the go-to-market strategy for its Sentry-Q platform.
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
AI generated stock image

Investing in Canadian medical stocks under $10

Healthcare stocks in Canada are publicly traded companies that operate in various sectors of the healthcare industry.

A potential breakthrough in spinal cord and optic nerve injury treatment

A potential breakthrough in spinal cord and optic nerve injury treatment
  • Research
  • 1 min
  • 19 December 2024 07:01 (EST)
AI generated stock image

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

The TSX has experienced a rocky week, marked by five consecutive sessions of declines, but several stocks offer compelling opportunities.

Quipt boosts revenue and customers in Q4

Quipt Home Medical (TSX:QIPT) reported its financial results for Q4 and fiscal year ended September 30, 2024
Image via Cloud DX

Cloud DX sells subsidiary, completes first stage of restructuring

Cloud DX (TSXV:CDX) reported the sale of its wholly owned subsidiary, Cloud Diagnostics Canada ULC to 1493907 B.C. Ltd.
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
Image of a brain via Alpha Cognition

Alpha Cognition sees promising data for military-related trauma treatment

Alpha Cognition (CSE:ACOG) announced preclinical data to support continued development of ALPHA-1062 to treat mild traumatic brain injury.
The nervous system

NurExone Biologic announces important test results

NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing its ExoPTEN to treat patients with acute spinal cord injuries.
  • Research
  • 4 mins
  • 11 December 2024 06:59 (EST)